|
1
|
Chen MX, Deng BY, Liu ST, Wang ZB and Wang
SZ: Salusins: Advance in cardiovascular disease research. J Pharm
Pharmacol. 75:363–369. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shichiri M, Ishimaru S, Ota T, Nishikawa
T, Isogai T and Hirata Y: Salusins: Newly identified bioactive
peptides with hemodynamic and mitogenic activities. Nat Med.
9:1166–1172. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu XL, Zeng Y, Zhao C, He MZ, Wang F and
Zhang W: Salusin-β induces smooth muscle cell proliferation by
regulating cyclins D1 and E expression through MAPKs signaling
pathways. J Cardiovasc Pharmacol. 65:377–385. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Esfahani M, Saidijam M, Najafi R, Goodarzi
MT and Movahedian A: The effect of salusin-β on expression of pro-
and anti-inflammatory cytokines in human umbilical vein endothelial
cells (HUVECs). ARYA Atheroscler. 14:1–10. 2018.PubMed/NCBI
|
|
5
|
Wang Z, Takahashi T, Saito Y, Nagasaki H,
Ly NK, Nothacker HP, Reinscheid RK, Yang J, Chang JK, Shichiri M
and Civelli O: Salusin beta is a surrogate ligand of the mas-like G
protein-coupled receptor MrgA1. Eur J Pharmacol. 539:145–150. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Arkan A, Atukeren P, Ikitimur B, Simsek G,
Koksal S, Gelisgen R, Ongen Z and Uzun H: The importance of
circulating levels of salusin-α, salusin-β, and heregulin-β1 in
atherosclerotic coronary arterial disease. Clin Biochem. 87:19–25.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Aydin S and Aydin S: Salusin-alpha and
-beta expression in heart and aorta with and without metabolic
syndrome. Biotech Histochem. 89:98–103. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen H and Jin G: Downregulation of
Salusin-β protects renal tubular epithelial cells against high
glucose-induced inflammation, oxidative stress, apoptosis and lipid
accumulation via suppressing miR-155-5p. Bioengineered.
12:6155–6165. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Khoramipour K, Chamari K, Hekmatikar AA,
Ziyaiyan A, Taherkhani S, Elguindy NM and Bragazzi NL: Adiponectin:
Structure, physiological functions, role in diseases, and effects
of nutrition. Nutrients. 13:11802021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Q, Liu S, Zhai A, Zhang B and Tian G:
AMPK-mediated regulation of lipid metabolism by phosphorylation.
Biol Pharm Bull. 41:985–993. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Trudel P, Provost S, Massie B, Chartrand P
and Wall L: pGATA: A positive selection vector based on the
toxicity of the transcription factor GATA-1 to bacteria.
Biotechniques. 20:684–693. 1996.PubMed/NCBI
|
|
12
|
Yu F, Li X, Wang F, Liu Y, Zhai C, Li W,
Ma L and Chen W: TLTC, a T5 exonuclease-mediated low-temperature
DNA cloning method. Front Bioeng Biotech. 11:11675342023.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y, Ndzouboukou JB, Lin X, Hou H,
Wang F, Yuan L, Gan M, Yao Z, Fu H, Cao J and Fan X: SARS-CoV-2
evolves to reduce but not abolish neutralizing action. J Med Virol.
95:e282072023. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sen P, Qadri S, Luukkonen PK,
Ragnarsdottir O, McGlinchey A, Jäntti S, Juuti A, Arola J,
Schlezinger JJ, Webster TF, et al: Exposure to environmental
contaminants is associated with altered hepatic lipid metabolism in
non-alcoholic fatty liver disease. J Hepatol. 76:283–293. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Alannan M, Fayyad-Kazan H, Trézéguet V and
Merched A: Targeting lipid metabolism in liver cancer.
Biochemistry. 59:3951–3964. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Wang S, Zhang J, Zhang M, Zhang H,
Gong G, Luo M, Wang T and Mao X: Salusin-β is superior to salusin-α
as a marker for evaluating coronary atherosclerosis. J Int Med Res.
48:3000605209038682020.PubMed/NCBI
|
|
17
|
Kołakowska U, Kuroczycka-Saniutycz E,
Wasilewska A and Olański W: Is the serum level of salusin-β
associated with hypertension and atherosclerosis in the pediatric
population? Pediatr Nephrol. 30:523–531. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang WJ, Jiang X, Gao CC and Chen ZW:
Salusin-β participates in high glucose-induced HK-2 cell
ferroptosis in a Nrf-2-dependent manner. Mol Med Rep. 24:6742021.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou CH, Liu LL, Wu YQ, Song Z and Xing
SH: Enhanced expression of salusin-β contributes to progression of
atherosclerosis in LDL receptor deficient mice. Can J Physiol
Pharmacol. 90:463–471. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fang H and Judd RL: Adiponectin regulation
and function. Compr Physiol. 8:1031–1063. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pascolutti R, Erlandson SC, Burri DJ,
Zheng S and Kruse AC: Mapping and engineering the interaction
between adiponectin and T-cadherin. J Biol Chem. 295:2749–2759.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Katsiki N, Mantzoros C and Mikhailidis DP:
Adiponectin, lipids and atherosclerosis. Curr Opin Lipidol.
28:347–354. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Niepolski L and Grzegorzewska AE: Salusins
and adropin: New peptides potentially involved in lipid metabolism
and atherosclerosis. Adv Med Sci. 61:282–287. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Herzig S and Shaw RJ: AMPK: Guardian of
metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol.
19:121–135. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cantó C and Auwerx J: AMP-activated
protein kinase and its downstream transcriptional pathways. Cell
Mol Life Sci. 67:3407–3423. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fang K, Wu F, Chen G, Dong H, Li J, Zhao
Y, Xu L, Zou X and Lu F: Diosgenin ameliorates palmitic
acid-induced lipid accumulation via AMPK/ACC/CPT-1A and
SREBP-1c/FAS signaling pathways in LO2 cells. BMC Complement Altern
Med. 19:2552019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Z, Ni L, Zhang L, Zha D, Hu C, Zhang
L, Feng H, Wei X and Wu X: Empagliflozin regulates the
AdipoR1/p-AMPK/p-ACC pathway to alleviate lipid deposition in
diabetic nephropathy. Diabetes Metab Syndr Obes. 14:227–240. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
McGarry JD, Leatherman GF and Foster DW:
Carnitine palmitoyltransferase I. The site of inhibition of hepatic
fatty acid oxidation by malonyl-CoA. J Biol Chem. 253:4128–4136.
1978. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Saggerson D: Malonyl-CoA, a key signaling
molecule in mammalian cells. Annu Rev Nutr. 28:253–272. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dai J, Liang K, Zhao S, Jia W, Liu Y, Wu
H, Lv J, Cao C, Chen T, Zhuang S, et al: Chemoproteomics reveals
baicalin activates hepatic CPT1 to ameliorate diet-induced obesity
and hepatic steatosis. Proc Natl Acad Sci USA. 115:E5896–E5905.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu L, Yao L, Wang S, Chen Z, Han T, Ma P,
Jiang L, Yuan C, Li J, Ke D, et al: 6-gingerol improves ectopic
lipid accumulation, mitochondrial dysfunction, and insulin
resistance in skeletal muscle of ageing rats: Dual stimulation of
the AMPK/PGC-1α signaling pathway via plasma adiponectin and
muscular adipoR1. Mol Nutr Food Res. 63:e18006492019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Iwabu M, Yamauchi T, Okada-Iwabu M, Sato
K, Nakagawa T, Funata M, Yamaguchi M, Namiki S, Nakayama R, Tabata
M, et al: Adiponectin and adipoR1 regulate PGC-1alpha and
mitochondria by Ca(2+) and AMPK/SIRT1. Nature. 464:1313–1319. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen L, Xin FJ, Wang J, Hu J, Zhang YY,
Wan S, Cao LS, Lu C, Li P, Yan SF, et al: Conserved regulatory
elements in AMPK. Nature. 498:E8–10. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Long JK, Dai W, Zheng YW and Zhao SP:
miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK
pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
Mol Med. 25:262019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhu X, Zhou Y, Cai W, Sun H and Qiu L:
Salusin-β mediates high glucose-induced endothelial injury via
disruption of AMPK signaling pathway. Biochem Biophys Res Commun.
491:515–521. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shichiri M, Nonaka D, Lee LJ and Tanaka K:
Identification of the salusin-β receptor using proteoliposomes
embedded with endogenous membrane proteins. Sci Rep. 8:178652018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Watanabe T, Nishio K, Kanome T, Matsuyama
TA, Koba S, Sakai T, Sato K, Hongo S, Nose K, Ota H, et al: Impact
of salusin-alpha and -beta on human macrophage foam cell formation
and coronary atherosclerosis. Circulation. 117:638–648. 2008.
View Article : Google Scholar : PubMed/NCBI
|
